SPDR S&P Kensho Future Security ETF (ARCA: FITE)

最新ニュース SPDR S&P Kensho Future Security ETF (ARCA:FITE)

Technology

Industrials

Healthcare

Communication Services

Other

Consumer Cyclical

Real Estate

Energy

Consumer Defensive

Financial Services

Utilities

Basic Materials

Under normal market conditions, the fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index is comprised of U.S.-listed equity securities (including depositary receipts) of companies domiciled across developed and emerging markets worldwide which are included in the Future Security sector as determined by a classification standard produced by the index provider. The fund is non-diversified.

Viasat Inc

Oceaneering International Inc

Varonis Systems Inc

SentinelOne Inc

F5 Networks Inc.

Parsons Corporation Com

Lockheed Martin Corp

Moog Inc

Check Point Software Technologies Ltd.

Northrop Grumman Corp.

SPDR S&P Kensho Future Security ETF

Fitell Corp

Above Food Ingredients Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abve#NASDAQ">ABVE</a>) (NASDAQ: ABVE.W), a leader in sustainable, vertically integrated food systems ("Above Food"), has signed a Letter of Intent (LOI) to acquire Palm Global Technologies Ltd. ("Palm Global"), <a href="http://www.palmglobal.ai" title="www.palmglobal.ai">www.palmglobal.ai</a>, a next-generation innovator in technology, sustainability, and global food markets. This acquisition positions Above Food to expand its reach into transformative sectors, including advanced Agri-Tech, FinTech and carbon credit securitization.
The partnership between Above Food and Palm Global marks a pivotal step forward towards the goal of ensuring global food security, combining Above Food's vertically integrated systems with Palm Global's groundbreaking technologies, strategic alliances, and global reach to create an inclusive, more sustainable future.
Palm Global aims to address food security, sustainability, financial inclusion and economic development at scale. Its leading-edge technology platforms and frontline super-apps, built on proprietary AI, blockchain, and decentralized finance ("DeFi") technologies, drive economic empowerment, education and sustainable growth in underserved global markets by supporting tens of millions of farmers throughout Africa, Southeast Asia and the Americas.
To accelerate adoption of its technology by farmers, Palm Global is partnering with governments, global NGOs and world-renowned institutions. Among them are the Peace for Life Foundation, and its agreement with Dicastero par la Cultura e l'Educazione (part of Roman Curia and the Holy See of the Catholic Church) ; IIMSAM (a United Nations-affiliated Intergovernmental Institution targeting malnutrition), Alpha MBM Investment LLC. <a href="http://www.alphambm.com" title="www.alphambm.com">www.alphambm.com</a>, Promax United Investment LLC. <a href="http://www.promaxunited.com" title="www.promaxunited.com">www.promaxunited.com</a>, Pro-Natura International. <a href="http://www.pronatura.org/en/" title="www.pronatura.org/en/">www.pronatura.org/en/</a>, and other global organizations. These partnerships are invaluable as Palm Global rolls out across large parts of Africa, Latin America (including Mexico and Brazil) and Southeast Asia (including Indonesia).
Palm Global's platforms and solutions have been developed by an elite technology team, renowned for their contributions to scaling some of the world's largest payments apps; the largest of which has in excess of one billion active monthly users.
Through this acquisition, Above Food will leverage Palm Global's global partnerships to develop, utilize, and maximize its industry-leading research and development capabilities in agronomy and genomics. By combining these capabilities with Palm Global's access to tens of millions of hectares of land farmed by millions of farmers, the enlarged company will be uniquely positioned to enable initiatives such as regenerative agricultural and grow-to-order food. This adaptable approach will support market shifts, strengthen global food security, and create solutions tailored to evolving consumer and agricultural needs.
Palm Global's Board of Directors and its Advisory Board include industry luminaries such as Peter Knez, former Co-Chief Investment Officer of BlackRock, His Highness Sheikh Mohammed Bin Maktoum Bin Juma Al Maktoum of the Dubai Royal Family, Her Excellence Yenny Wahid (Director of The Wahid Institute), and Muayad Kafesha (Deputy Secretary General of IIMSAM - Observer to the UN, ECOSOC, NY - HQRS). These individuals bring unparalleled expertise and influence, solidifying Palm Global's position as a global force in Agri-tech and sustainability.
The LOI outlines a share exchange valuing full ownership of Palm Global at approximately $180 million. Definitive agreements are expected during February 2025, with approvals and closing to follow swiftly thereafter. Upon closing, Peter Knez will assume the role of Chairman and CEO of the combined companies, strengthening Above Food's position in high growth markets. Lionel Kambeitz will continue to provide leadership as an Executive Director and Jason Zhao will remain in office as CFO.

Penny Stocks

ABVE

Above Food Signs LOI To Acquire The Palm Global Group; The LOI Outlines A Share Exchange Valuing Full Ownership Of Palm Global At ~$180M

News

Contracts

MTEK

Maris-Tech Has Received A New Order For Its Jupiter Nano System To Be Delivered To A New Defense Company In Eastern Europe

Guidance

CORRECTION: Xcel Energy Affirms FY2025 Adj EPS Guidance Of $3.75-$3.85 vs $3.82 Est

Morgan Stanley analyst Adam Jonas maintains Harley-Davidson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOG#NYSE">HOG</a>) with a Equal-Weight and lowers the price target from $33 to $31.

Price Target

Analyst Ratings

Morgan Stanley Maintains Equal-Weight on Harley-Davidson, Lowers Price Target to $31

WIIM

QCOM

Qualcomm shares are trading lower after Piper Sandler cut its price target on the stock from $205 to $190.

Global

KVUE

Kenvue Exec Says Had A Reduction In Customer Orders In China, Due To Temporary Disruption In Distribution Network For Essential Health And Skin Health Brands; Co Is In The Process Of Replacing These Underperforming Distributors; Says It Is Considering Price Hikes In Response To Potential Tariffs But Has Not Taken A Final Decision Given The Fluidity Of The Situation

Lightspeed Commerce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LSPD#NYSE">LSPD</a>) just disclosed its Q3 earnings on Thursday, February 6, 2025 at 07:00 AM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
Lightspeed Commerce beat estimated earnings by 20.0%, reporting an EPS of $0.12 versus an estimate of $0.1.
Revenue was up $40.44 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
The company beat on EPS by $0.02 in the last quarter, resulting in a 1.0% increase share price change the following day.
Here's a look at Lightspeed Commerce's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.11</td>
<td>0.08</td>
<td>0.06</td>
<td>0.05</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.13</td>
<td>0.10</td>
<td>0.06</td>
<td>0.08</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>274.08M</td>
<td>259.66M</td>
<td>224.92M</td>
<td>235.86M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>277.18M</td>
<td>266.09M</td>
<td>230.22M</td>
<td>239.69M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Lightspeed Commerce <a href="https://www.benzinga.com/quote/LSPD/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

LSPD

Lightspeed Commerce Earnings Report: Q3 Overview

The earnings results for First Ntl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FXNC#NASDAQ">FXNC</a>) for Q4 were made public on Thursday, February 6, 2025 at 07:30 AM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
First Ntl beat estimated earnings by 32.0%, reporting an EPS of $0.66 versus an estimate of $0.5.
Revenue was up $10.93 million from the same period last year.
<h3>Historical Earnings Summary</h3>
The company beat on EPS by $0.03 in the previous quarter, leading to a 0.0% increase share price change the next day.

To track all earnings releases for First Ntl <a href="https://www.benzinga.com/quote/FXNC/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FXNC

First Ntl: Q4 Earnings Insights

Citigroup analyst Spiro Dounis maintains Enterprise Prods Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPD#NYSE">EPD</a>) with a Buy and raises the price target from $36 to $37.

Citigroup Maintains Buy on Enterprise Prods Partners, Raises Price Target to $37

Reddit Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) has been riding a bullish wave, surging 338.46% in the past year, 33.30% year-to-date, and 23.22% over <a href="https://www.benzinga.com/quote/RDDT/news">the past month</a>. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020625&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="626" height="490" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06062239/Screenshot-2025-02-06-at-4.52.25-PM.png" alt="" class="wp-image-769117" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06062239/Screenshot-2025-02-06-at-4.52.25-PM.png 626w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06062239/Screenshot-2025-02-06-at-4.52.25-PM-300x235.png 300w" sizes="(max-width: 626px) 100vw, 626px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020625&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
RDDT stock is soaring above its five, 20, 50, and 200-day simple moving averages (SMAs), signaling strong buying pressure. Yet, just as RDDT stock gains traction ahead of its Q4 earnings in six days, it finds itself in a situation with none other than Tesla Inc&#8216;s CEO Elon Musk.
<h2 class="wp-block-heading">RDDT Stock On A Tear, But Overbought Warnings Loom</h2>
Reddit's technicals remain firmly bullish. The stock sits at $224.00, well above its eight-day SMA of $207.25, 20-day SMA of $188.24 and 50-day SMA of $172.38—a clear bullish signal. 
Even its 200-day SMA at $94.89 is miles behind, cementing its long-term strength. The MACD indicator at 13.60 also points to continued momentum.
But there's a catch—Reddit's Relative Strength Index (RSI) is flashing 77.88, deep in overbought territory. That could mean a cooldown is coming, especially with potential headline risks on the horizon.
Read Also: <a href="https://www.benzinga.com/general/social-media/25/01/43291797/exclusive-will-social-media-users-leave-over-politics-new-poll-shows-this-platform-hurt-most" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Will Social Media Users Leave Over Politics? New Poll Shows This Platform Hurt Most</a>
<h2 class="wp-block-heading">Musk Vs. Reddit: A Digital Showdown</h2>
As RDDT stock soars, Reddit finds itself clashing with one of the internet's most influential voices—Elon Musk. The billionaire sparked a crackdown on Reddit communities after accusing users of making violent threats against his employees, The Verge <a href="https://www.theverge.com/news/606904/reddit-rules-bans-violence-doxing-elon-musk-doge">reported</a>.
In response, Reddit temporarily banned r/WhitePeopleTwitter for 72 hours and permanently shut down r/IsElonDeadYet.
Musk, who has long positioned himself as a free speech advocate, <a href="https://x.com/elonmusk/status/1886501169154957587">posted </a>on X, stating, &#8216;They have broken the law.&#8217; Musk himself has been involved in legal battles over online speech, including a now-dismissed lawsuit against the Centre for Countering Digital Hate.
Tensions between Musk and Reddit communities have been boiling over. More than 100 subreddits recently <a href="https://www.bbc.com/news/articles/c77r1p887e5o">blocked</a> X links in protest after Musk made a controversial arm <a href="https://www.washingtonpost.com/video/politics/elon-musk-stirs-controversy-over-hand-gesture-at-trump-rally/2025/01/21/0aca1099-57fb-45f7-9a27-cddb1a5f6ef4_video.html">gesture </a>at a Trump rally.
Despite the drama, RDDT stock has momentum. With earnings coming up on Feb. 12, investors will be watching closely. Can Reddit sustain its rally, or will the Musk-fueled controversy be the first crack in the armor?
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/02/43488205/trump-media-technology-trading-volume-falls-amid-expensive-valuations-and-bearish-charts-heres-what-technical-analysis-for-djt-stock-shows">Trump Media &amp; Technology Trading Volume Falls Amid Expensive Valuations And Bearish Charts: Here&#8217;s What Technical Analysis For DJT Stock Shows</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Social Media

Technicals

Tech

Trading Ideas

General

RDDT

Reddit's Stock Soars Even As Musk-Related Tensions Rise

On Thursday,&nbsp;Bristol Myers Squibb &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) posted fourth-quarter revenues of $12.34 billion, beating the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $11.57 billion</a>.
Sales increased 8% year-over-year, or 9% when adjusted for foreign exchange impacts, primarily driven by the Growth Portfolio and higher demand for Eliquis, partially offset by the impact of generics on Sprycel, Revlimid, Abraxane&nbsp;and&nbsp;Pomalyst.
Growth Portfolio worldwide revenues increased to $6.36 billion, representing growth of 21% on a reported basis or 23% when adjusted for&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43523532/bristol-myers-squibb-reports-fourth-quarter-and-full-year-financial-results-for-2024" rel="noreferrer noopener">foreign exchange impacts</a>.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/24/12/42638844/large-biopharma-lags-market-jp-morgans-2025-outlook-on-eli-lilly-merck-and-more" rel="noreferrer noopener">Big Biopharma Trails Behind The Market: JP Morgan&#8217;s 2025 Outlook on Eli Lilly, Merck, and More</a>
Opdivo sales increased 4% to $2.48 billion. The arthritis drug Orencia generated sales of $1 billion, up 2%. Sales of another cancer drug, Yervoy, increased 19% to $675 million.
Anemia drug Reblozyl generated $547 million in the quarter sales, up 71% from a year ago. Revenues for the Legacy Portfolio were $5.98 billion, down 4%.
The company reported an adjusted EPS of $1.67, down from $1.70 a year ago, beating the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $1.46</a>.
Bristol Myers Squibb expanded its existing strategic productivity initiative to include approximately $2 billion in additional annualized cost savings by the end of 2027.
In the third quarter of 2024, the company outlined cost-saving initiatives and anticipated&nbsp;internal cost savings of <a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41655052/bristol-myers-squibb-boosts-2024-outlook-on-strong-demand-for-blood-thinner-med-new-drugs-drive-q" rel="noreferrer noopener">around $1.5 billion in 2025</a>.
Guidance:&nbsp;Bristol Myers Squibb forecasts 2025 adj EPS of $6.55-$6.85 compared to the consensus of $6.92. The company forecasts 2025 sales of $45.5 billion versus the consensus of $46.27 billion.
The U.S. pharma giant estimates revenue forecast reflects, as previously expected, the near-term impact of generics across Revlimid,&nbsp;Pomalyst, Sprycel&nbsp;and&nbsp;Abraxane, which is expected to result in a revenue decline of approximately 18-20% of the Legacy Portfolio.
This is expected to be partially offset by the continued strength of the Growth Portfolio. This guidance also reflects an approximate $500 million expected negative impact to revenue due to foreign exchange.
Price Action: At the last check on Thursday, BMY stock was down 4.04% to $57.30.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43526541/honeywell-q4-earnings-revenue-and-eps-beat-pursues-planned-split-into-3-public-companies-by-2026" target="_blank" rel="noreferrer noopener">Honeywell Q4 Earnings: Revenue And EPS Beat, Pursues Planned Split Into 3 Public Companies By 2026</a></li>
</ul>
Image via Bristol-Myers Squibb

Biotech

Large Cap

Health Care

Movers

Bristol Myers Squibb Warns Near-Term Impact Due To Generics On 2025 Sales Forecast, Outlines $2 Billion In Additional Cost Cuts

Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) with a Buy and raises the price target from $107 to $122.

Citigroup Maintains Buy on Boston Scientific, Raises Price Target to $122

Morgan Stanley analyst Ole Slorer maintains Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) with a Overweight and raises the price target from $258 to $267.

Morgan Stanley Maintains Overweight on Fiserv, Raises Price Target to $267

<a href="https://www.lyft.com/blog/posts/lyft-and-anthropic-team-up-to-redefine-customer-obsessed-ai" title="https://www.lyft.com/blog/posts/lyft-and-anthropic-team-up-to-redefine-customer-obsessed-ai">https://www.lyft.com/blog/posts/lyft-and-anthropic-team-up-to-redefine-customer-obsessed-ai</a>

LYFT

Lyft Announces They Will Work With Anthropic To Create New Lyft Products That Transform The Rideshare Experience For Millions Of Riders And Drivers

Citigroup analyst James Hardiman maintains Harley-Davidson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOG#NYSE">HOG</a>) with a Neutral and lowers the price target from $31 to $29.

Citigroup Maintains Neutral on Harley-Davidson, Lowers Price Target to $29

Rave Restaurant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAVE#NASDAQ">RAVE</a>) reported quarterly earnings of $0.04 per share. This is unchanged from the same period last year. The company reported $2.87 million in sales this quarter. This is a 4.48 percent increase over sales of $2.75 million the same period last year.

RAVE

Rave Restaurant Gr Q2 EPS $0.04, Same YoY, Sales $2.87M Up From $2.75M YoY

Morgan Stanley analyst Dara Mohsenian maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Equal-Weight and lowers the price target from $85 to $81.

Morgan Stanley Maintains Equal-Weight on Estee Lauder Cos, Lowers Price Target to $81

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

FUFU

BitFuFu Produced 83 BTC From Self-Mining Operations And 200 BTC For Cloud-Mining Customers In Jan.

Updates Net Debt to Net Capitalization Ratio Expectations
Beazer Homes USA, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BZH#NYSE">BZH</a>) today announced that it is accelerating the pace of its share repurchases in light of recent share price dislocation. The Company will continue to repurchase shares pursuant to the Company's previously authorized share repurchase program, under which approximately $24.8 million remains available.
Since January 30th, after reporting earnings for the first quarter of 2025, the Company has repurchased approximately $4.1 million of its shares at a weighted average price of $21.86. The Company plans to increase the pace of its repurchases in light of current market conditions.
Considering the acceleration of its share repurchase program, the Company also announced that debt reduction is expected to moderate in the near term. Specifically, the Company now projects its net debt to net capitalization ratio will be in the low 30% range by the end of fiscal 2026 and will be in the mid-to-high 30% range by the end of fiscal 2025. Notwithstanding this near-term moderation in leverage reduction, the Company remains committed to its long-term goal of reducing its net debt to net capitalization ratio below 30%. Furthermore, the Company reaffirmed its outlook for its two other Multi-Year Goals: reaching 200 active communities by the end of fiscal 2026 and starting 100% of its homes qualified as Zero Energy Ready by the end of calendar 2025.

Beazer Homes Accelerates Share Repurchases $4.1M Already Bought At $21.86 Average Price Since Q1 2025 Earnings Report; Projects Its Net Debt To Net Capitalization Ratio Will Be In The Low 30% Range By The End Of Fiscal 2026 And Will Be In The Mid-To-High 30% Range By The End Of Fiscal 2025

Cantor Fitzgerald analyst Brett Knoblauch maintains MicroStrategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) with a Overweight and raises the price target from $613 to $619.

MSTR

Cantor Fitzgerald Maintains Overweight on MicroStrategy, Raises Price Target to $619

Trump 2.0: Signs executive orders, reverses Biden policies, halts TikTok ban

CES 2025: Physical AI Is Here

Trump-packed with action: orders U.S. out of WHO, emergency at Mexico border, targets 'woke' culture

Trump-packed with action: exit WHO, emergency at Mexico border, targets 'woke' culture

Comments

SPDR S&P Kensho Future Security ETF

ニュース

最新ニュース SPDR S&P Kensho Future Security ETF (ARCA:FITE)

ニュース

パートナーシップ

ベンジンガ・グローバル